Journal of Vascular Surgery
Volume 48, Issue 5, Supplement , Pages S55-S80 , November 2008

Complications of arteriovenous hemodialysis access: Recognition and management

  • Frank T. Padberg Jr, MD

      Affiliations

    • Section of Vascular Surgery, Department of Surgery, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark and Section of Vascular Surgery, Veterans Affairs New Jersey Health Care System, East Orange, NJ
    • Corresponding Author InformationCorrespondence: Frank Padberg, MD, Doctors Office Center, 90 Bergen St, Ste 7200, Newark, NJ 07103
    • ,
  • Keith D. Calligaro, MD

      Affiliations

    • Section of Vascular Surgery, Pennsylvania Hospital, Philadelphia, Pa
    • ,
  • Anton N. Sidawy, MD, MPH

      Affiliations

    • Surgical Services, Veterans Affairs Medical Center, George Washington and Georgetown Universities, Washington, DC

Received 7 August 2008 ,Accepted 18 August 2008.

References 

  1. United States Renal Data System. USRDS 2007 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007;
  2. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2006. Am J Kidney Dis. 2006;48(suppl):S176–S247
  3. Spergel L, Jennings W. Creating AV fistulae in all eligible hemodialysis patients (Fistula First National Vascular Access Improvement Initiative; CD and DVD set). 2005;
  4. Sidawy AN, Gray R, Besarab A, Henry M, Ascher E, Silva M. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg. 2002;35:603–610
  5. *Kaufman JS, O'Connor TZ, Zhang JH, Cronin RE, Fiore LD, Ganz MB. Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol. 2003;14:2313–2321
  6. Brenner M. Effect of renal failure on hemostasis (Brenner and Rector's the kidney). 7th edition. New York, NY: Saunders; 2004;pp 2173-8
  7. *Mannucci PM, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, Mecca G. Deamino-8-D-Arginine vasopressin shortens the bleeding time in uremia. N Engl J Med. 1983;308:8–12
  8. Livio M, Gotti E, Marchesi D, Mecca G, Remuzzi G, deGaetano E. Uraemic bleeding: role of anemia and beneficial effect of red cell transfusions. Lancet. 1982;2:1013–1015
  9. *Steiner RW, Coggins C, Carvalho ACA. Bleeding time in uremia: a useful test to assess clinical bleeding. Am J Hematol. 1979;7:107–117
  10. Janson PA, Jubelierer SJ, Weinstein MJ, Deykin D. Treatment of the bleeding tendency in uremia with cryoprecipitate. N Engl J Med. 1980;303:1318–1322
  11. Moia M, Vizzotto , Cattaneo M, Mannucci PM, Casati S, Ponticelli C. Improvements in the haemonstatic defect of uraemia after treatment with recombinant human erythropoietin. Lancet. 1987;2:1227–1229
  12. *Livio M, Mannucci PM, Viganó GL, Mingardi G, Lombardi R, Mecca G. Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med. 1986;315:731–735
  13. Noris , Remuzzi G. Uremic bleeding: closing the circle after 30 years of controversies?. Blood. 1999;94:2574–2589
  14. Triulzi DJ, Blumberg N. Variability in response to cryoprecipitate treatment fo hemostatic defects in uremia. Yale J Biol Med. 1990;63:1–7
  15. *Viganó GL, Mannucci PM, Lattuada A, Harris A, Remuzzi G. Subcutaneous Desmopressin (DDAVP) shortens the bleeding time in uremia. Am J Hematol. 1989;31:32–35
  16. Mannucci PM, Ruggeri ZM, Pareti FI, Capitanio A. Deamino-8-D-Arginine vasopressin shortens the bleeding time in uremia. Lancet. 1977;2:869–872
  17. Canavese C, Salomone M, Pacitti A, Mangiarotti G, Calitri V. Reduced response of uraemic bleeding time to repeated doses of desmopressin. Lancet. 1985;1:867–868
  18. Rydzewski A, Rowinski M, Mysliwiec M. Shortening of bleeding time after intranasal administration of 1-deamino-8-D-Arginine vasopressin to patients with chronic uremia. Folia Haematol. 1986;113:823–830
  19. *Viganó GL Benigni A, Mendogni D, Mingardi G, Mecca G, Remuzzi G. Recombinant human erythropoietin to correct uremic bleeding. Am J Kidney Dis. 1991;18:44–49
  20. *Viganó G, Gaspari F, Locatelli M, Pusineri F, Bonati M, Remuzzi G. Dose-effect and pharmacokinetics of estrogens given to correct bleeding time in uremia. Kidney Int. 1988;34:853;-8
  21. *Viganó G, Zoja C, Corna D, Rossini M, Pusineeri F, Garattini S. 17β-Estradiol is the most active component of the conjugated estrogen mixture active on uremic bleeding by a receptor mechanism. J Pharm Exp Ther. 1990;252:344–348
  22. Sloand JA, Schiff MJ. Beneficial effect of low-dose transdermal estrogen on bleeding time and clinical bleeding in uremia. Am J Kidney Dis. 1995;26:22–26
  23. Castillo R, Lozano T, Escolar G, Revert L, Lopez J, Ordinas A. Defective platelet adhesion on vessel subendothelium in uremic patients. Blood. 1986;68:337–342
  24. Zoja C, Noris M, Corna D, Viganó G, Perico N, deGaetano G, et al. L-Arginine, the precursor of nitric oxide, abolishes the effect of estrogens on bleeding time in experimental uremia. Lab Invest. 1991;65:479–483
  25. *Crowther MA, Clase CM, Margetts PJ, Julian J, Lambert K, Sneath D. Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial. J Am Soc Nephrol. 2002;13:2331–2337
  26. *Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA. 2008;299:2164–2171
  27. Stack AG, Bloembergen WE. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis population. Am J Kidney Dis. 2001;38:992–1000
  28. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis, and risk factors. Kidney Int. 1998;47:884–890
  29. Foley RN, Guo H, Snyder JJ, Gilbertson DT, Collins AJ. Septicemia in the United States dialysis population, 1991 to 1999. J Am Soc Nephrol. 2004;15:1038–1045
  30. Tokars JI, Miller ER, Stein G. New national surveillance system for hemodialysis associated infections: initial results. Am J Kidney Dis. 2002;30:288–295
  31. Cohen G, Haag-Weber M, Horl WH. Immune dysfunction in uremia. Kidney Int Suppl. 1997;62:S79–S82
  32. Anding K, Gross P, Rost JM, Allgaier D, Jacobs E. The influence of uraemia and haemodialysis on neutophil phagocytosis and antimicrobial killing. Nephrol Dial Transplant. 2003;18:2067–2073
  33. Chonchol M. Neutrophil dysfunction and infection risk in end stage renal disease. Semin Dial. 2006;19:291–296
  34. Butterly DW, Schwab SJ. Dialysis access infections. Curr Opin Nephrol Hypertens. 2000;9:631–635
  35. Perecesenschi G, Blum M, Aviram A, Spirer ZH. Imparied neutrophil response to acute bacterial infection in dialyzed patients. Arch Intern Med. 1981;141:1301–1302
  36. Hanicki Z, Cichocki T, Komorowska Z, Sułowicz W, Smoleński O. Some aspects of cellular immunity in untreated and maintenance hemodialysis patients. Nephron. 1979;23:273–275
  37. Fowler VG, McIntyre LM, Yeaman MR, Peterson GE, Reiller LB, Corey GR, et al. In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. J Inf Dis. 2000;182:1251–1254
  38. *Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol. 1998;9:869–876
  39. Thomson PC, Stirling CM, Geddes CC, Morris ST, Mactier RA. Vascular access in haemodialysis patients: a modifiable risk factor for bacteremia and death. Q J Med. 2007;100:415–422
  40. Stevenson KB, Hannah EL, Lowder CA, Adcox MJ, Davidson RL, Mallea MC, et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 2002;39:549–555
  41. *Tokars JI, Light P, Anderson J, Miller ER, Parrish J, Armistead N, et al. A prospective study of vascular access infections at seven outpatient hemodialysis centers. Am J Kidney Dis. 2001;37:1232–1240
  42. Kantrowitz LG, Comstock JA, Landwehr DM, Dalton HP, Mayhall CG. A prospective study of infections in hemodialysis patients: patient hygiene and other risk factors for infection. Infect Control Hosp Epidemiol. 1988;9:534–541
  43. Ayus JC, Sheikh-Hamad D. Silent infection in clotted hemodialysis access grafts. J Am Soc Nephrol. 1998;9:1314–1317
  44. Brunner MC, Mitchell RS, Baldwin JC, James DR, Olcott C, Mehigan JT. Prosthetic graft infection: limitation of indium white blood cell scanning. J Vasc Surg. 1986;3:42–48
  45. Williamson MR, Boyd CM, Read RC, Thompson BW, Barnes RW, Shah HR, et al. 111 In-labeled leukocytes in the detection of prosthetic vascular graft infections. Am J Roentgenol. 1986;147:173–176
  46. Taylor B, Sigley RD, May KJ. Fate of infected and eroded hemodialysis grafts and autogenous fistulas. Am J Surg. 1993;165:632–636
  47. Padberg FT, Smith SM, Eng RHK. Accuracy of disincorporation for identification of vascular graft infection. Arch Surg. 1995;130:183–187
  48. Ryan SV, Calligaro KD, Scharff J, Dougherty MJ. Management of infected prosthetic dialysis arteriovenous grafts. J Vasc Surg. 2004;39:73–78
  49. Geary KJ, Timkeiwicz ZM, Harrison HN, Fiore WM, Geary JE, Green RM, et al. Differential effects of a gram negative and a gram positive infection on autogenous and prosthetic grafts. J Vasc Surg. 1990;11:339–347
  50. Ballard JL, Bunt TJ, Malone JM. Major complications of angioaccess surgery. Am J Surg. 1992;164:229–232
  51. Calligaro KD, Veith FJ, Schwartz ML, Dougherty MJ, DeLaurentis DA. Differences in early versus late extracavitary arterial graft infections. J Vasc Surg. 1995;22:680–688
  52. Padberg FT, Lee BC, Curl GR. Hemoaccess site infection. Surg Gynecol Obstet [now J Am Coll Surg]. 1992;174:103–108
  53. Zibari GB, Rohr MS, Landreneau MD, Bridges RM, deVault GA, Petty FH, et al. Complications from permanent hemodialysis vascular access. Surgery. 1998;104:681–686
  54. Churchill D, Taylor DW, Cook RJ, LaPlante P, Barre P, Cartier P, et al. Canadian hemodialysis morbidity study. Am J Kidney Dis. 1992;19:214–234
  55. Palder SB, Kirkman RL, Whittemore AD, Hakim RM, Lazarus JM, Tilney NL. Vascular access for hemodialysis (Patency rates and results of revision). Ann Surg. 1985;202:235–239
  56. Morgan AP. Editorial comment. Arch Surg. 1974;108:732
  57. Silverman NA, Gunnells JC, Stickle DL. Surgical treatment of Staphylococcus aureus endarteritis in a hemodialysis arteriovenous fistula. Arch Surg. 1974;108:730–732
  58. Foley RN, Collins AJ. End-stage renal disease n the United States: An update from the United States Renal Data System. J Am Soc Nephrol. 2007;18:2644–2648
  59. *Keuter XH, De Smet AA, Kessels AG, van der Sande FM, Welten RJ, Tordoir JH. A randomized multicenter study of the outcome of brachial-basilic arteriovenous fistula and prosthetic brachial-antecubital forearm loop as vascular access for hemodialysis. J Vasc Surg. 2008;47:395–401
  60. Gifford RRM. Management of tunnel infections of dialysis polytetrafluoroethylene grafts. J Vasc Surg. 1985;2:854–858
  61. Schwab DP, Taylor SM, Cull DL, Langan EM, Snyder BA, Sullivan TM, et al. Isolated arteriovenous dialysis access graft segment infection: the results of segmental bypass and partial graft excision. Ann Vasc Surg. 2000;14:63–66
  62. *Rooijens PP, Burgmans JP, Yo TI, Hop WC, de Smet AA, van den Dorpel MA. Autogenous radial-cephalic or prosthetic brachial-antecubital forearm loop AVF in patients with compromised vessels? A randomized multicenter study of the patency of primary hemodialysis access. J Vasc Surg. 2000;42:481–487
  63. Borrero E, Doscher W. Chronic perigraft seromas in PTFE grafts. J Cardiovasc Surg. 1988;29:46–49
  64. Ahn SS, Machleder HI, Gupta R, Moore WS. Perigraft seroma: clinical, histology, and Serologic correlates. Am J Surg. 1987;154:173–178
  65. Blumenberg RM, Gelfand ML, Dale WA. Perigraft seromas complicating arterial grafts. Surgery. 1985;97:194–203
  66. Eid A, Lyass S. Acute perigraft seroma simulating anastomotic bleeding of a PTFE graft applied as an arteriovenous shunt for hemodialysis. Ann Vasc Surg. 1996;10:290–291
  67. Tyndall SH, Shepard AD, Wilczewski JM, Reddy DJ, Elliott JR, Ernst CB. Groin lymphatic complications after arterial reconstruction. J Vasc Surg. 1994;19:858–863
  68. Najibi S, Bush RL, Terramani TT, Chaikof EL, Gunnoud AB, Lumsden AB, et al. Covered stent exclusion of dialysis access pseudoaneuryms. J Surg Res. 2002;106:15–19
  69. Vesely T. Use of stent grafts to repair hemodialysis graft-related pseudoaneurysms. J Vasc Interv Radiol. 2005;16:1301–1307
  70. Ryan JM. Using a covered stent (Wallgraft) to treat pseudoaneurysms of dialysis grafts and fistulas. Am J Radiol. 2002;106:15–19
  71. Brescia MJ, Cimmino OE, Appel K, Hurwitz BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med. 1966;275:1089–1092
  72. Haimov M, Baez A, Neff M, Slifkin R. Complication of arteriovenous fistulae for hemodialysis. Arch Surg. 1975;110:708–712
  73. Kerstein M, May CJ. Acute and chronic venous insufficiency in the finger. Angiology. 1976;27:265–266
  74. Vanherweghem JL, Yassine T, Goldman M, Vandenbosch G, Delcour C, Struyven J, et al. Subclavian vein thrombosis: a frequent complication of subclavian vein cannulation for hemodialysis. Clin Nephrol. 1986;26:235–238
  75. Teruya TH, Abou-Zamzam AM, Limm W, Wong L, Wong L. Symptomatic subclavian vein stenosis and occlusion in hemodialysis patients with transvenous pacemakers. Ann Vasc Surg. 2003;17:526–529
  76. Sticherling C, Chough SP, Baker RL, Wasmer K, Oral H, Tada H, et al. Prevalence of central venous venous occlusion in patients with chronic defibrillator leads. Am Heart J. 2001;141:813–816
  77. Padberg FT, Blackburn GL, Bistrian BR, Ruggiero J. Central venous cannulation for parenteral nutrition. Ann Surg. 1981;193:264–270
  78. Abdullah BJ, Mohammad N, Sangkar JV, Abd Aziz YF, Gan GG, Goh KY, et al. Incidence of upper limb venous thrombosis associated with peripherally inserted central catheters (PICC). Br J Radiol. 2005;78:596–600
  79. Allen AW, Megargell JL, Brown DB, Lynch FC, Singh H, Singh Y, et al. Venous thrombosis associated with the placement of peripherally inserted central catheters. J Vasc Interv Radiol. 2000;11:1309–1314
  80. Joffe HV, Kucher N, Tapson VF, Goldhaber SZ. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation. 2004;110:1605–1611
  81. Prandoni P, Polistena P, Bernardi E, Cogo A, Casara D, Veriato F, et al. Upper-extremity deep vein thrombosis: risk factors, diagnosis, and complications. Arch Intern Med. 1997;157:57–62
  82. Kalra M, Gloviczki P, Andrews JC, Cherry KJ, Bower TC, Panneton JM, et al. Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease. J Vasc Surg. 2003;38:215–223
  83. Bornak A, Wicky S, Ris HB, Probst H, Milesi I, Corpataux JM. Endovascular treatment of stenoses in the superior vena cava syndrome caused by non-tumoral lesions. Eur Radiol. 2003;13:950–956
  84. Wisselink W, Money SR, Becker MO, Rice KL, Ramee SR, White CJ, et al. Comparison of operative reconstruction and percutaneous balloon dilatation for central venous obstruction. Am J Surg. 1993;166:200–205
  85. Cuadra S, Padberg FT, Turbin RE, Farkas J, Frohman LP. Cerebral venous hypertension and blindness: a reversible complication. J Vasc Surg. 2005;42:792–795
  86. Eklöf B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki , Kistner RL. Revision of the CEAP classification for chronic venous disorders: a consensus statement. J Vasc Surg. 2004;40:1248–1252
  87. Irvine C, Holt P. Hand venous hypertension complicating arteriovenous fistula construction for haemodialysis. Clin Exp Dermatol. 1989;14:289–290
  88. Swayne LC, Manstein C, Somers R, Cope C. Selective digital venous hypertension: a rare complication of hemodialysis arteriovenous fistula. Cardiovasc Intervent Radiol. 1983;6:61–62
  89. Brakman M, Faber WR, Zeegelaar JE, Bousema MT, vanProosdij JL, Kerchhaert JA. Venous hypertension of the hand caused by hemodialysis shunt: immunofluorescence studies of pericapillary cuffs. J Am Acad Dermatol. 1994;31:23–26
  90. Wood ML, Reilly GD, Smith GT. Ulceration of the hand secondary to a radial arteriovenous fistula: a model for varicose ulceration. BMJ. 1993;287:1167–1168
  91. Burnand KG, Whimster I, Naidoo A, Browse NL. Peri-capillary fibrin in the ulcer-bearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration. BMJ. 1982;285:1071–1072
  92. Deshmukh N, Reppert M. Venous ulceration of the hand secondary to a Cimino fistula. Mil Med. 1993;158:752–753
  93. Garvin PJ, Codd JE. Severe hand venous hypertension with an end-to-side radiocephalic fistula: case report. Mo Med. 1979;76:210–211
  94. Dikow R, Schwenger V, Zeler M, Ritz E. Do AV fistulas contribute to cardiac mortality in hemodialysis patients?. Semin Dial. 2002;15:14–17
  95. Begin V, Ethier J, Dumont M, Leblanc M. Prospective evaluation of the intra-access flow of recently created native arteriovenous fistulae. Am J Kidney Dis. 2002;40:1277–1282
  96. Schwab SJ, Quarles LD, Middleton JP, Cohan RH, Saeed M, Dennis VW. Hemodialysis-associated subclavian vein stenosis. Kidney Int. 1988;33:1156–1159
  97. Lumsden AB, MacDonald MJ, Isiklar H, Martin LG, Kikeri D, Harker LA, et al. Central venous stenosis in the hemodialysis patient: incidence and efficacy of endovascular treatment. Cardiovasc Surg. 1997;5:504–509
  98. Bhatia DS, Money SR, Ochsner JL, Crockett DE, Charman D, Dharamsey SA, et al. Comparison of surgical bypass and percutaneous balloon dilatation with primary stent placement in the treatment of central venous obstruction in the dialysis patient: one-year follow-up. Ann Vasc Surg. 1996;10:452–455
  99. Rizvi AZ, Kalra M, Bjarnason H, Bower TC, Schleck C, Gloviczki P. Benign superior vena cava syndrome: Stenting is now the first line of treatment. J Vasc Surg. 2008;47:372–380
  100. Schonfeld R, Hermans H, Novick A, Brener B, Cordero P, Eisenbud D, et al. Stenting of proximal venous obstructions to maintain hemodialysis access. J Vasc Surg. 1994;19:532–538
  101. Puskas JD, Gertler JP. Internal jugular to axillary vein bypass for subclavian vein thrombosis in the setting of brachial arteriovenous fistula. J Vasc Surg. 1994;19:939–942
  102. Currier CB, Widder S, Ali A, Kuusisto E, Sidawy A. Surgical management of subclavian and axillary vein thrombosis in patients with a functioning arteriovenous fistula. Surgery. 1986;100:25–28
  103. McCann RL. Axillary grafts for difficult hemodialysis access. J Vasc Surg. 1996;24:257–262
  104. El-Sabrout A, Duncan JM. Right atrial bypass grafting for central venous obstruction associated with dialysis access: another treatment option. J Vasc Surg. 1999;29:472–478
  105. Doty DB, Doty JR, Jones KW. Bypass of superior vena cava: fifteen year's experience with spiral vein graft for obstruction of superior vena cava caused by benign disease. J Thorac Cardiovasc Surg. 1990;99:889–895
  106. *Huber TS, Buhler AG, Seeger JM. Evidenced-based data for the hemodialysis access surgeon. Semin Dial. 2004;17:217–223
  107. Depner TA, Krivitski NJ. Clinical measurement of blood flow in hemodialysis access fistulae and grafts by ultrasound dilution. ASAIO J. 1995;41:M745–M749
  108. Bosman PJ, Boereboom FTJ, Bakker CJ, Mall WPT, Eikelboom BC, Blankestijn PJ, et al. Access flow measurements in hemodialysis patients: in vivo validation of an ultrasound dilution technique. J Am Soc Nephrol. 1996;7:966–969
  109. *Moist LM, Churchill DN, House AA, Millward SF, Elliott JE, Kribs SW. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. J Am Soc Nephrol. 2003;14:2645–2653
  110. *Robbin ML, Oser RF, Lee JY, Heudebert GR, Mennenmeyer ST, Allon M. Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney Int. 2006;69:730–735
  111. Schwab SJ, Raymond JR, Saeed M, Newman GE, Dennis PA, Bollinger RR. Prevention of hemodialysis fistula thrombosis: early detection of venous stenoses. Kidney Int. 1989;36:707–711
  112. *Lumsden AB, MacDonald J, Kikeri D, Cotsonis GA, Harker LA, Martin LG. Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetraflouroethylene arteriovenous grafts: results of a prospective randomized study. J Vasc Surg. 1997;26:382–392
  113. *Beathard GA. Gianturco self-expanding stent in the treatment of stenosis in dialysis access grafts. Kidney Int. 1993;43:872–877
  114. *Hoffer EK, Sultan S, Herskowitz MM, Daniels ID, Sclafani SJ. Prospective randomized trial of a metallic intravascular stent in hemodialysis graft maintenance. J Vasc Interv Radiol. 1997;8:965–973
  115. *Brooks JL, Sigley RD, May KJ, Mack RM. Transluminal angioplasty versus surgical repair for stenosis of hemodialysis grafts: a randomized study. Am J Surg. 1987;153:830–831
  116. Rajan DK, Bunston S, Misra S, Pinto R, Lok CE. Dysfunctional autogenous arteriovenous fistulas: Outcomes after angioplasty—are there clinical predictors of patency?. Radiology. 2004;232:508–515
  117. Kian K, Asif A. Cephalic arch stenosis. Semin Dial. 2008;21:78–82
  118. Chen JC. Venous obstruction in patients with autogenous hemodialysis arteriovenous access. Ann Vasc Surg. 2005;19:629–635
  119. *Sidawy AN, Spergel LM, Besarab A, Allon M, Jennings WC, Padberg FT. The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg. 2008;48(suppl S):2S–25S
  120. *Patel U, Bratby MJ, Brookes MJ, Lehmann ED. Angioplasty and/or stenting for arteriovenous fistula and graft stenoses in hemodialysis patients. Cochrane Database Syst Rev. 2005;3:CD005424
  121. White JJ, Bander SJ, Schwab SJ, Churchill DN, Moist LM, Beathard GA, et al. Opinion: is percutaneous transluminal angioplasty an effective intervention for arteriovenous graft stenosis?. Semin Dial. 2005;18:190–202
  122. Storey BG, George CR, Stewart JH, Tiller DJ, May J, Sheil AG. Embolic and ischemic complications after anastomosis of radial artery to cephalic vein. Surgery. 1969;66:325–327
  123. Matolo N, Kastagir B, Stevens LE, Chrysanthakopoulos S, Weaver DH, Klinkman H. Neurovascular complications of brachial arteriovenous fistula. Am J Surg. 1971;121:716–719
  124. Bolton DF, Driedger AA, Lindsay RM. Ischemic neuropathy in uremic patient caused by bovine AV shunts. J Neurol Neurosurg Psych. 1979;42:810–814
  125. Morsy AH, Kulbaski M, Chen C, Isiklar H, Lumsden AB. Incidence and characteristics of patients with hand ischemia after a hemodialysis access procedure. J Surg Res. 1998;74:8–10
  126. Odland MD, Kelly PH, Ney AL, Andersen RC, Bubrick MP. Management of dialysis associated steal syndrome complicating upper extremity arteriovenous fistulas. Surgery. 1991;110:664–669
  127. Redfern AB, Zimmerman ND. Neurologic and ischemic complications of upper extremity vascular access for dialysis. J Hand Surg (Am). 1995;20:199–204
  128. Lazarides MK, Staramos DN, Panagopoulos GN, Tzilalis VD, Eleftheriou GJ, Dayantas JN. Indications for surgical treatment of angioaccess-induced arterial “steal.”. J Am Coll Surg. 1998;187:422–426
  129. Wyrtzes L, Markley HG, Fischer M, Alfred HJ. Brachial neuropathy after brachial to antecubital vascular shunts for chronic hemodialysis. Neurology. 1987;37:1398–1400
  130. Tordoir JHM, Dammers R, van der Sande FM. Upper extremity ischemia and hemodialysis vascular access. Eur J Vasc Endovasc Surg. 2004;27:1–5
  131. Hye RJ, Wolf YG. Ischemic monomelic neuropathy: an under-recognized complication of hemodialysis access. Ann Vasc Surg. 1994;8:578–582
  132. Schanzer A, Nguyen LL, Owens CD, Schanzer H. Use of digital pressure measurements for the diagnosis of AV access-induced hand ischemia. Vasc Med. 2006;11:227–231
  133. Jennings WC. Creating arteriovenous fistulas in 132 consecutive patients (Exploiting the proximal radial artery arteriovenous fistula: reliable, safe, simple forearm and upper arm access). Arch Surg. 2006;141:27–32
  134. Minion DJ, Moore E, Endean E. Revision using distal inflow: A novel approach to dialysis-associated steal syndrome. Ann Vasc Surg. 2005;19:625–628
  135. Schanzer H, Skadany M, Haimov M. Treatment of angioaccess-induced ischemia by revascularization. J Vasc Surg. 1992;16:861–866
  136. Riggs JE, Moss AH, Labosky DA, Liput JH, Morgan JJ, Gutmann L. Upper extremity ischemic monomelic neuropathy: a complication of vascular access procedures in uremic diabetic patients. Neurology. 1989;39:997–998
  137. Miles AM. Upper limb ischemia after vascular access surgery: differential diagnosis and management. Semin Dial. 2000;13:312–315
  138. Yeager RA, Moneta GL, Edwards JM, Landry GJ, Taylor LM, McConnell DB, et al. Relationship of hemodialysis access to finger gangrene in patients with end-stage reanl disease. J Vasc Surg. 2002;36:245–249
  139. Guerra A, Raynaud A, Beyssen B, Pagny JY, Sapoval M, Angel C. Arterial percutaneous angioplasty in upper limbs with vascular access devices for haemodialysis. Nephrol Dial Transplant. 2002;17:843–851
  140. Valji K, Hye RJ, Roberts AC, Oglevie SB, Ziegler T, Bzookstein JJ. Hand Ischemia in patients with hemodialysis access grafts: angiographic diagnosis and treatment. Radiology. 1995;196:697–701
  141. Khan FA, Vesely TM. Arterial problems associated with dysfunctional hemodialysis grafts: evaluation of patients at high risk for arterial disease. J Vasc Interv Radiol. 2002;13:1109–1114
  142. Wilbourn AJ, Furlan AJ, Hulley W, Ruschhaupt W. Ischemic monomelic neuropathy. Neurology. 1983;33:447–451
  143. Kaku DA, Malamut RI, Frey DJ, Parry GJ. Conduction block an early sign of reversible injury in ischemic monomelic neuropathy. Neurology. 1993;43:1126–1130
  144. Berman SS, Gentile AT, Glickman MH, Mills JL, Hurwitz RL, Westerband A, et al. Distal revascularization-interval ligation for limb salvage and maintenance of dialysis access in ischemic steal syndrome. J Vasc Surg. 1997;26:393–404
  145. Kwun KB, Schanzer H, Finkler N, Haimov M, Burrows L. Hemodynamic Evaluation of angioaccess procedures for hemodialysis. Vasc Surg. 1979;13:170–177
  146. Gradman WS, Cohen W, Haji-Aghaii M. Arteriovenous fistula construction in the thigh with transposed superficial femoral vein: our initial experience. J Vasc Surg. 2001;33:968–975
  147. Goff CD, Sato DT, Bloch PH, DeMasi RJ, Gregory RT, Gayle RG, et al. Steal syndrome complicating hemodialysis access procedures: can it be predicted?. Ann Vasc Surg. 2000;14:138–144
  148. Levine MP. The hemodialysis patient and hand amputation. Am J Nephrol. 2001;21:498–501
  149. Plumb TJ, Lynch TG, Adelson AB. Treatment of steal syndrome in a distal radiocephalic arteriovenous fistula using intravascular coil embolization. J Vasc Surg. 2008;47:457–459
  150. Rivers SP, Scher LA, Veith FJ. Correction of steal syndrome secondary to hemodialysis access fistulas: a simplified quantitative technique. Surgery. 1992;112:593–597
  151. Meyer F, Müller JS, Grote R, Halloul Z, Lippert H, Bürger T. Fistula banding-success-promoting approach in peripheral steal syndrome. Zentralb Chir. 2002;127:685–686
  152. Gradman WS, Laub J, Cohen W. Femoral vein transposition for arteriovenous hemodialysis access: improved patient selection and intraoperative measures reduce postoperative ischemia. J Vasc Surg. 2005;41:279–284
  153. Schanzer H, Schwartz M, Harrington E, Haimov M. Treatment of ischemia due to “steal” by arteriovenous fistula with distal artery ligation and revascularization. J Vasc Surg. 1988;7:770–773
  154. Schanzer H, Eisenberg D. Management of steal syndrome resulting from dialysis access. Semin Vasc Surg. 2004;17:45–49
  155. Zanow J, Kruger U, Scholz H. Proximalization of the arterial inflow: a new technique to treat access-related ischemia. J Vasc Surg. 2006;43:1216–1221
  156. Gracz KC, Ing TS, Soung L-S, Armbruster KFW, Seim SK, Merkel FK. Proximal forearm fistula for maintenance hemodialysis. Kidney Int. 1977;11:71–75
  157. Anderson CB, Codd JR, Graff RA, Groce MA, Harter HR, Newton WT. Cardiac failure and upper extremity arteriovenous dialysis fistulas. Arch Intern Med. 1976;136:292–297
  158. MacRae JM, Pandeya S, Humen DP, Krivitski , Lindsay RM. Arteriovenous fistula-associated high-output cardiac failure: a review of Mechanisms. Am J Kidney Dis. 2004;43:E21–E22
  159. Engelberts I, Tordoir JH, Boon ES, Schreij G. High-output cardiac failure due to excessive shunting in a hemodialysis access fistula: an easily overlooked diagnosis. Am J Nephrol. 1995;15:323–326
  160. Reis GJ, Hirsch AT, Come PC. Detection and treatment of high-output cardiac failure resulting from a large hemodialysis fistula. Cathet Cardiovasc Diagn. 1988;14:263–265
  161. Clarkson MR, Giblin L, Brown A, Little D, Donohoe J. Reversal of pulmonary hypertension after ligation of a brachiocephalic arteriovenous fistula. Am J Kidney Dis. 2002;40:E8
  162. Nakhoul F, Yiglia M, Gilman R, Reisner SA, Abassi Z. The pathogensis of pulmonary hypertension in haemodialysis patients via arterio-venous access. Nephrol Dial Transplant. 2005;20:1686–1692
  163. Young PR, Rohr MS, Marterre WF. High-output cardiac failure secondary to a brachiocephalic arteriovenous hemodialysis fistula: two cases. Am Surg. 1996;64:239–242
  164. Pandeya S, Lindsay RM. The relationship between cardiac output and access flow during hemodialysis. ASAIO. 1999;45:135–138
  165. Kelly CJ, Augustine C, Rooney BP, Bouchier-Hayes DJ. An investigation of the pathophysiology of ischemic neuropathy. Eur J Vasc Surg. 1991;5:535–539
  166. Dyck PJ, Conn DL, Okazaki H. Necrotizing angiopathic neuropathy: three-dimensional morphology of fiber degeneration related to sites of occluded vessels. Mayo Clin Proc. 1972;47:461–475
  167. Warren DJ, Otieno LS. Carpal tunnel in patients on intermittent haemodialysis. Post Med J. 1975;51:450–452
  168. Halter SK, DeLisa JA, Stolov WC, Scardapame D, Sherrard DJ. Carpal tunnel syndrome in chronic renal dialysis patients. Arch Phys Med Rehabil. 1992;62:197–201
  169. Naito M, Ogata K, Goya T. Carpal tunnel syndrome in chronic renal dialysis patients: clinical evaluation of 62 hands and results of operative treatment. J Hand Surg [Br]. 1987;12:366–374
  170. Semer NB, Goldberg NJ, Cuono CB. Upper extremity entrapment neuropathy and tourniquet use in patients undergoing hemodialysis. J Hand Surg [Am]. 1989;14:897–900
  171. Tzamaloukas AH, Kunzelman CL, Carroll LL, Scremin AE, Merlin TL, Avasthi PS, et al. Carpal tunnel syndrome in patients on chronic hemodialysis. Dial Transplant. 1988;17:525–527
  172. Hirasawa Y, Ogura T. Carpal tunnel syndrome in patients on long-term haemodialysis. Scand J Reconstr Hand Surg. 2000;34:373–381
  173. Katz JN, Simmons BP. Clinical practice: carpal tunnel syndrome. N Engl J Med. 2002;346:1807–1812
  174. Rempel D, Evanoff B, Amadio PC, deKrom M, Franklin G, Franzblau A, et al. Consensus criteria for the classification of carpal tunnel syndrome in epidemiologic studies. Am J Public Health. 1998;88:1447–1451
  175. Bicknell JM, Lim AC, Raroque HG, Tzamaloukas H. Carpal tunnel syndrome, subclinical median mononeuropathy, and peripheral polyneuropathy: common early complications of chronic peritoneal dialysis and hemodialysis. Arch Phys Med Rehabil. 1991;72:378–381
  176. Gousheh J, Iranpour A. Association between carpal tunnel syndrome and arteriovenous fistula in hemodialysis patients. Plas Reconstr Surg. 2005;116:508–513
  177. Dickinson JC, Kleinert JM. Acute carpal-tunnel syndrome caused by a calcified median artery. J Bone Joint Surg Am. 1991;73:610–611
  178. Barfred T, Højlund AP, Bertheussen K. Median artery in carpal tunnel syndrome. J Hand Surg [Am]. 1985;10:864–867
  179. Konishiike T, Hashizume H, Nishida K, Inoue H, Moriwaki K. Cubital tunnel syndrome in a patient in long-term haemodialysis. J Hand Surg [Br]. 1994;19:636–637
  180. Borman H, Akinbingol G, Maral T, Sozay S. Entrapment neuropathy of the upper extremity in hemodialysis patients. Plast Reconstr Surg. 2002;109:2598–2599
  181. Borgatti PP, Lusenti T, Franco V, Anelli A, Brancaccio D. Guyon's syndrome in a long term hemodialysis patient. Nephrol Dial Transplant. 1991;6:734–735
  182. The K/DOQI Clinical Practice Guidelines on Chronic Kidney Disease Work Group. National Kidney Foundation K/DOQI clinical practice guidelines for chronic renal disease: evaluation, classification, and stratification (Part 6. Association of GFR with complications in adults. Guideline 11 association of level of GFR with neuropathy). Am J Kid Dis. 2002;39(suppl 1):S1–S266
  183. Benz RL, Siegfreid JW, Teehan BP. Carpal tunnel syndrome in dialysis patients: comparison between continuous ambulatory peritoneal dialysis and hemodialysis populations. Am J Kidney Dis. 1988;11:473–476
  184. Gagnon RF, Lough JO, Bourgouin PA. Carpal tunnel syndrome and amyloidosis associated with continuous ambulatory peritoneal dialysis. CMAJ. 1988;139:753–755
  185. Gelberman RH, Hergenroeder PT, Hargens AR, Lundborg GN, Akeson WH. The carpal tunnel syndrome (A study of carpal canal pressures). J Bone Joint Surg Am. 1981;63:380–383
  186. Gelberman RH, Szabo RM, Williamson RV, Hargens AR, Yaru NC, Minteer-Convery MA. Tissue pressure threshold for peripheral nerve viability. Clin Orthop Relat Res. 1983;178:285–291
  187. Gejyo F, Narita I. Current clinical and pathogenetic understanding of β-2m amyloidosis in long-term haemodialysis patients. Nephrology. 2003;8:S45–S49
  188. *Atroshi I, Larsson GU, Ornstein E, Hofer M, Johnssnon R, Ranstam J. Outcomes of endoscopic surgery compared with open surgery for carpal tunnel syndrome among employed patients: randomized controlled trial. BMJ. 2006;332:1473–1476
  189. Gilbert MS, Robinson A, Baez A, Gupta S, Glabman S, Haimov M. Carpal tunnel syndrome in patients who are receiving long-term renal hemodialysis. J Bone Joint Surg Am. 1988;70:1145–1153
  190. Burn DJ, Bates D. Neurology and the kidney. J Neurol Neurosurg. 1998;65:810–821
  191. Bolton CF. Peripheral neuropathies associated with chronic renal failure. Can J Neurol Sci. 1980;7:89–96
  192. *Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM. The prevalence of staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study. Neurology. 1993;43:817–824
  193. Bolton CF, McKeown MJ, Chen R, Toth B, Remtulla H. Subacute uremic and diabetic polyneuropathy. Muscle Nerve. 1997;20:59–64
  194. Said G, Goulon-Goeau C, Slama G, Tchobruoutsky G. Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus: a clinical and pathological study. N Engl J Med. 1992;326:1257–1263
  195. Ropper AH. Accelerated neuropathy of renal failure. Arch Neurol. 1993;51:536–539
  196. Asbury AK, Victor M, Adams RD. Uremic polyneuropathy. Arch Neurol. 1963;8:113
  197. Said G, Boudier L, Selva J, Zingraff J, Drueke T. Different patterns of ischemic polyneuropathy: clinicopathologic study. Neurology. 1983;33:567–574
  198. Ahonen RE. Peripheral neuropathy in uremic patients and in renal transplant recipients. Acta Neuropathol. 1981;54:43–53
  199. Dyck PJ, Johnson J, Nelson RA, Lambert EH, O'Brien PC. Uremic neuropathy (III. Controlled study of restricted protein and fluid diet and infrequent hemodialysis versus conventional hemodialysis treatment). Mayo Clin Proc. 1975;50:641–649
  200. Dyck PJ. New understanding and treatment of diabetic neuropathy. New Engl J Med. 1992;326:1287–1288
  201. Ropper AH, Brown RH. Adams & Victor's principles of neurology. 8th edition. New York, NY: McGraw-Hill; 2005;
  202. *The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986
  203. Navarro X, Sutherland DE, Kennedy WR. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol. 1998;44:149–150

 STATEMENT OF CONFLICT OF INTEREST: These authors report that they have no conflicts of interest with the sponsor of this supplement article or products discussed in this article.

PII: S0741-5214(08)01432-8

doi: 10.1016/j.jvs.2008.08.067

Journal of Vascular Surgery
Volume 48, Issue 5, Supplement , Pages S55-S80 , November 2008

Article Tools